GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Nothing GTCB management can do about this type sh**<

What they can do is not finance with PIPE’s.

My working assumption is that shorting on the come almost always occurs prior to the announcement of a PIPE but the evidence is usually not strong enough to bring charges.

--
GTC had about $40M in the bank at the end of 1Q07 (#msg-19329705) and product revenues, albeit modest ones, will begin very soon. Worrying unduly about PIPE’s at this point in time is tantamount to barking up the wrong tree, IMO.